1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia

BACKGROUND: Posaconazole is approved in adults for prophylaxis and treatment of invasive fungal disease. Two formulations that offer weight-based dosing—intravenous (IV) and oral powder for suspension (PFS)—are being evaluated in children. A population pharmacokinetic (popPK) approach was used to ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Winchell, Gregory A, de Greef, Rik, Wrishko, Rebecca E, Mangin, Eric, Waskin, Hetty, Bruno, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808851/
http://dx.doi.org/10.1093/ofid/ofz360.1422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808851/
http://dx.doi.org/10.1093/ofid/ofz360.1422

Ejemplares similares